Track market-moving stories before they get noisy

Investors tend not to think of consumer stocks as growth names. These companies often have conservative management, rarely matching the returns of higher-flying growth stocks, and in many cases, pay dividends.

Fortunately, some of these names have a track record of delivering long-term returns and will likely continue to do so. Knowing that, investors can buy these three consumer staples stocks and should earn significant returns by holding them for decades.

Image source: Getty Images.

Constellation Brands Constellation Brands (STZ +2.84%) is a leading alcohol company that has dealt with internal and external threats. Sales have suffered as consumers across generations have reduced alcohol consumption.

Also, while it distributes America's No. 1 beer, Modelo, the beer's ties to Mexico stoked worries about tariff threats. Internally, the company did not foresee the falling consumption patterns and relied too heavily on wine and spirit brands that did not perform well.

However, investors have priced these challenges into the stock, perhaps overly so. That prompted Warren Buffett to invest some of Berkshire Hathaway's cash into the stock before he retired, and this was likely a wise decision. Moreover, Constellation has divested some of its underperforming wine and spirit brands.

The divestiture was partially responsible for an 11% sales decline in fiscal 2026 (ended Feb. 28). Nonetheless, it generated $1.8 billion in free cash flow in that fiscal year. That allowed it to repurchase shares and fund its dividend. That payout, which has risen every year since 2015, pays investors $4.12 per share annually, a 2.6% cash return.

Today's Change

(

2.84

%) $

4.06

Current Price

$

147.18

Furthermore, in fiscal 2027, the company forecasts net sales will remain steady at the midpoint. The stock has also risen 15% since the beginning of the year. Considering its P/E ratio of just 16, one could argue that this Warren Buffett stock is absurdly cheap right now.

PepsiCo Like Constellation, PepsiCo (PEP +0.28%) provides a unique opportunity to investors as it adapts to evolving consumer tastes. Aside from its flagship cola, Mountain Dew, Gatorade, Doritos, and Quaker Oats are among the products under its umbrella.

In recent years, consumers have become increasingly leery of sugary drinks and processed foods, leading to a reduction in sales. PepsiCo has responded by changing the ingredients in many of its products and buying some brands associated with healthier offerings, such as Siete Foods.

Its recovery is showing some promising signs. In its fiscal first quarter (ended March 21), net revenue grew by nearly 9%, well above the 2% in fiscal 2025. Also, even though free cash flow was negative $406 million in fiscal Q1, it improved from year-ago levels. Investors should note that the free cash flow was nearly $7.7 billion in fiscal 2025.

That cash repurchased shares and supported its dividend, which has increased for 54 straight years. At $4.69 per share annually, it yields almost 3.7%.

Today's Change

(

0.28

%) $

0.41

Current Price

$

144.14

Analysts forecast a 5% revenue increase in fiscal 2026, indicating its market pivot is working. Furthermore, its stock has risen by almost 10% this year, and at a P/E ratio of 24, it is likely not too late to invest in a probable recovery in PepsiCo stock.

Kimberly-Clark Similar to PepsiCo, Kimberly-Clark (KMB +1.10%) has built its business around trusted brands. It owns Kleenex, Huggies, Cottonelle, and others. Also, its upcoming acquisition of Kenvue, which was once the consumer health division of Johnson & Johnson, will place more familiar brands like Tylenol and Listerine under its umbrella.

Over the last year, the stock has suffered amid rising input costs, expenses related to a company restructuring, and the $48.7 billion cost of acquiring Kenvue. In that time, the stock lost more than one-fourth of its value.

Today's Change

(

1.10

%) $

1.12

Current Price

$

102.66

However, these moves could spark the beginnings of a recovery. In 2025, its net sales fell by 2%. Also, it generated $1.6 billion in free cash flow in that year, down by 35% amid the restructuring.

Share levels remained steady, though it is on track to continue funding the dividend that has risen for 54 consecutive years. At $5.12 per share annually, it yields about 5.1%, enough to pay investors while they wait for a recovery.

Analysts anticipate net sales growth of around 3%. Moreover, its P/E ratio has fallen to 16, a level near multiyear lows. Between that valuation and its high-paying, growing dividend, any positive news could spark a recovery in the stock.

NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, May 5, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor.

ROCHESTER, N.Y., May 06, 2026 (GLOBE NEWSWIRE) -- Constellation Brands (NYSE: STZ), a leading beverage alcohol company, announced today that it has given notice for full redemption prior to maturity of all of its outstanding 3.700% Senior Notes due 2026 (CUSIP Number: 21036PAQ1) to be effected on May 18, 2026. As of May 6, 2026, there were $600.0 million in aggregate principal amount of the notes outstanding.

The redemption price for the notes, payable in cash, will be calculated pursuant to the formula set forth in the supplemental indenture relating to the notes.

This press release shall not constitute a notice of redemption of the notes. Information concerning the terms and conditions of the redemption of the notes is described in the notice distributed to holders of the notes by the trustee under the indenture and the applicable supplemental indenture governing the notes.

ABOUT CONSTELLATION BRANDS
Constellation Brands is an international producer and marketer of beer, wine, and spirits with operations in the U.S., Mexico, New Zealand, and Italy. Constellation’s brand portfolio includes Modelo Especial, Corona Extra, Modelo Cheladas, Pacifico, Victoria, The Prisoner Wine Company, Robert Mondavi Winery, Kim Crawford, Schrader Cellars, Lingua Franca, Mi CAMPO Tequila, and High West Whiskey.

FORWARD-LOOKING STATEMENTS
This news release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Statements which are not historical facts and relate to future plans, events, or performance, including statements regarding the redemption date and price, are forward-looking statements that are based upon management’s current expectations and are subject to risks and uncertainties. The forward-looking statements should not be construed in any manner as a guarantee that such events or results will in fact occur or will occur on the timetable contemplated hereby. All forward-looking statements speak only as of the date of this news release and Constellation undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. Detailed information regarding risk factors with respect to the company and the offering are included in the company’s filings with the SEC, including the prospectus and prospectus supplement for the offering.

PDF available: http://ml.globenewswire.com/Resource/Download/eebf28ef-7e1d-4a8a-9528-8eb4d653404d

There is a difference between a stock that pays a dividend and a stock built around the discipline of consistently paying one. The three companies below have structured their entire capital return philosophies around their commitments to grow those dividend checks year after year, through recessions, trade wars, management transitions, and every variety of market chaos. That consistency is the output of durable competitive positions that have earned the right to be viewed as long-term holdings.

Target: 235 dividend checks and counting Target (TGT +1.95%) has paid a dividend every single quarter since it went public in October 1967. This is a streak of 235 consecutive payments. It has raised its payouts for 54 straight years, a record that earns it entry into the exclusive club of Dividend Kings -- companies that have increased their annual payouts for at least 50 consecutive years.

The retail giant's stock is down roughly 45% from its 2021 peak and now trades near $129, a level not seen since 2018. Its dividend yield, as a result, has expanded to roughly 3.5%, one of Target's better income entry points in years. The next ex-dividend date is May 13, meaning investors who act this week will receive the June 1 payment.

The bear case on Target is real: Comparable sales growth has been flat to negative, tariff pass-through costs are rising, and after several years of boycotts and brand damage, the company is navigating a brand refresh under new CEO Jim Lee.

But the bull case for long-term holders is equally clear: Target operates in a category -- general merchandise retail -- where the digital and physical shopping experience is converging, and its scale, store network, and fulfillment infrastructure are competitive advantages that took decades to build. Investors who bought Target stock at any point of high pessimism over the past 50 years and held on have been rewarded with both capital appreciation and a dividend that was never cut, suspended, or missed.

Today's Change

(

1.95

%) $

2.59

Current Price

$

135.23

Nike: A stock at a 12-year low, but with a 24-year dividend-hiking streak Nike (NKE 1.61%) is in the middle of a turnaround, and the stock has priced in far more damage than the brand itself has actually sustained. The shares trade near $43, a level not seen since 2014, down roughly 76% from their 2021 all-time high. That is the kind of markdown that historically precedes meaningful long-term returns when the underlying brand remains intact.

This brand is still intact. CEO Elliott Hill -- a 32-year Nike veteran who came out of retirement to lead the recovery effort -- is executing what he calls a "Wholesale Renaissance," rebuilding the distribution relationships that its prior direct-to-customer sales strategy dismantled, and restoring Nike's presence in specialty running and sport channels that competitors like Hoka and On Holding have entered. In its fiscal 2026 third quarter, which ended Feb. 28, wholesale revenue rose 8% globally and 24% in North America, and the running category posted growth above 20% for the second straight quarter.

Meanwhile, Nike has raised its dividend for 24 consecutive years. Its next quarterly dividend of $0.41 per share, just declared in April, is payable July 1.

Today's Change

(

-1.61

%) $

-0.74

Current Price

$

45.22

Constellation Brands: The beer that America already chooses Constellation Brands (STZ +2.84%) owns Modelo Especial -- the No. 1 selling beer in the United States by volume. It owns Corona. It owns Pacifico. These are hugely popular beers in North America.

Today's Change

(

2.84

%) $

4.06

Current Price

$

147.18

The stock is down roughly 50% from its 2023 peak, trading near $148, which has lifted its dividend yield to approximately 2.8%. The company returned more than $900 million to shareholders in fiscal 2026 despite a challenging operating environment driven by consumer caution, higher tariff costs on Mexican imports, and the divestiture of its mainstream wine and spirits portfolio.

Image source: Getty Images.

That divestiture is the non-obvious positive in the Constellation story. The company shed its lower-margin wine brands to concentrate entirely on premium Mexican beer -- a segment that has taken sustained share from domestic brews for more than a decade. The underlying trend here is demographic: Latinos are the fastest-growing demographic group in the United States, and Modelo carries a level of brand equity that can't be unraveled by a trade war or a soft quarter.

For investors buying a dividend that has been maintained through real operational pressure, at a price that reflects maximum pessimism toward a brand that still dominates the No. 1 category in American drinking culture, the long-term math looks right.

Constellation Brands remains a Buy, supported by solid cash flow, strong brands, and a valuation that offers a margin of safety amid macro headwinds. FY26 free cash flow reached $1.79B, with FY27 guidance implying $1.6–$1.7B FCF and comparable EPS of $11.20–$11.90, reflecting ongoing consumer pressure. STZ's premium portfolio and disciplined capital allocation, including a 2.93% dividend yield and robust buybacks, should help deliver solid returns in an eventual consumer recovery.

Greg Abel's first quarter as Berkshire Hathaway's (BRKA +0.36%) (BRKB +0.16%) CEO is officially in the books. And things certainly seem at least a little bit different than how they were when Warren Buffett was at the helm.

With the exception of its expanded stake in Alphabet, which is now the conglomerate's fifth-largest holding, and a cut to its investment in Chevron, there wasn't much change in the company's top 10 equity positions -- which make up roughly 80% of the portfolio's value at recent prices.

There are still some big takeaways to glean from the seemingly small changes Abel made in Q1, however, that could make a meaningful impact on this ticker's long-term performance. Here are the three most important ones I see.

1. Not bothering with pointlessly small positions While Berkshire Hathaway's biggest holdings didn't change much last quarter, many of the smaller ones did. In addition to Charter Communications and Aon, Abel also shed longtime holdings Visa and Mastercard, along with a relatively recently acquired position in Amazon.

The common thread among the 16 stocks sold entirely in Q1? Not a single one of them accounted for more than 1% of the value of Berkshire Hathaway's entire stock portfolio. Even if any of these names were destined for big gains, it would have made little net impact.

Image source: The Motley Fool.

Honestly, I never understood why Buffett bothered with such small positions. They seemed like more of a distraction that Abel doesn't want.

2. Letting go of losers There's much to be said for being willing to hold onto a stock for Buffett's favorite holding period of "forever." There's also something to be said for being willing to bail out of an underperforming position -- even at a loss -- when it's clear that something's not panning out.

That's what Abel seems to think, anyway. Despite owning some of them for only a few quarters, Berkshire got out of positions in Pool Corp., UnitedHealth, and Domino's Pizza and sold most of its stake in Constellation Brands (STZ +2.84%), just to name a few. In most cases, these exits would have locked in a loss.

It's difficult to disagree with the decisions, though. For instance, while Constellation was a promising turnaround prospect when Berkshire first began accumulating it back in late 2024, it's since become clear that the booze business's headwind may be more secular than cyclical. Gallup reports the number of Americans who regularly consume alcohol reached a multidecade low last quarter. This weakness could last for a full generation.

Today's Change

(

2.84

%) $

4.06

Current Price

$

147.18

Ditto for health insurer UnitedHealth. The healthcare system's skyrocketing operating costs and subsequent price increases have reached untenable levels. The business will require a massive overhaul to repair, and it's not clear what it will look like afterward. Berkshire's managers know enough to know they can't afford to wait around for the unknown distant future while weighing the stock down in the present.

3. Willingness to invest in special situations The line dividing undervalued stocks and long-shot turnaround stories can sometimes be blurry. Buffett usually remained on the "undervalued" side of the fence and was rewarded for recognizing the right buying opportunities. His willingness to scoop up beaten-down Goldman Sachs shares in the midst of 2008's subprime mortgage meltdown, for example, ended up paying off handsomely. In retrospect, it was a no-brainer move.

Abel seems willing to strategically bet on companies with seemingly less resiliency than Goldman. In Q1, for example, he steered Berkshire into new stakes in Delta Air Lines and department store chain Macy's. While these companies aren't doomed, they're both facing serious systemic challenges. For instance, although Delta's revenue has continued to reliably grow, its bottom line has been mostly stagnant since 2016 largely because the highly competitive air travel business continues evolving in ways that pinch its profitability. As for Macy's, why would Abel want to own a piece of a brick-and-mortar retailer that's been reporting declining revenue since 2016? It may have something to do with the fact that Macy's owned real estate alone may be worth more than the company's current market cap.Now it's just a matter of figuring out how to unlock that value.

More to the point, these don't seem like businesses Warren Buffett would have bought into, recognizing something big would need to change to make them worth owning. Indeed, back in his 2007 letter to Berkshire shareholders, Buffett bluntly wrote, "The airline industry's demand for capital ever since that first flight has been insatiable. Investors have poured money into a bottomless pit, attracted by growth when they should have been repelled by it."

Today's Change

(

0.16

%) $

0.79

Current Price

$

486.57

Bonus: Fewer stocks, more wholly owned businesses... maybe Finally, while Berkshire Hathaway added or expanded stock positions during the first quarter, the cash hoard continues to grow, reaching a record $397 billion as of the end of March.

It's broadly understandable. Stocks as a whole are unusually expensive right now, with the S&P 500 (^GSPC +0.32%) priced at roughly 22 times its projected earnings.

Not every stock is wildly overvalued here, however. Indeed, data from Yardeni Research indicates that without the artificial intelligence (AI)-centric "Magnificent Seven" stocks' valuations factored in, the S&P 500's forward-looking price-to-earnings ratio is a much more palatable 19. Point being, there are reasonably priced equities out there, if Abel wants Berkshire Hathaway to buy them. He doesn't -- at least not yet.

So what does he want to do with all that cash? While he may be waiting for a more compelling economic backdrop to start making bigger equity investments, it's also possible this is the beginning of a more philosophical shift away from a somewhat broken stock market and toward more outright ownership of cash-generating businesses that Berkshire can wholly control. As a reminder, Berkshire Hathaway completed its acquisition of Occidental Petroleum's chemical business, OxyChem, at the beginning of this year. Although it already operates in the chemical space via Lubrizol and LiquidPower, Berkshire didn't really need to outright buy OxyChem. It just wanted to.

One deal doesn't make a trend. All trends, however, start with that first step. And honestly, less reliance on increasingly volatile stocks and more exposure to privately held businesses may be the best thing for Berkshire Hathaway shareholders for the foreseeable future.

ROCHESTER, N.Y., June 02, 2026 (GLOBE NEWSWIRE) -- Constellation Brands, Inc. (NYSE: STZ), a leading beverage alcohol company, announced today it will report financial results for its first quarter ended May 31, 2026, on Tuesday, June 30, 2026, after the close of the U.S. markets by posting the earnings release and financial tables, as well as other supporting materials, on the company’s investor relations website at ir.cbrands.com. A live conference call will be hosted at 8:00 a.m. ET on Wednesday, July 1, 2026, for analysts to discuss the company’s financial results, operating performance, strategic business initiatives, and financial outlook with President and Chief Executive Officer, Nicholas Fink, and Executive Vice President and Chief Financial Officer, Garth Hankinson.

The conference call can be accessed by dialing +1-877-407-9121 and entering conference identification number 13760976, beginning at 7:50 a.m. ET. A live, listen-only webcast of the conference call will be available on the company’s investor relations website at ir.cbrands.com under the News & Events section. When the conference call begins, financial information discussed on the call, and reconciliations of reported GAAP financial measures with comparable and other non-GAAP financial measures, will also be available on the company’s investor relations website under the Financial History section. For anyone unable to participate in the conference call, a replay will be available on the company’s investor relations website.

ABOUT CONSTELLATION BRANDS
Constellation Brands (NYSE: STZ) is a leading international producer and marketer of beer, wine, and spirits with operations in the U.S., Mexico, New Zealand, and Italy. Our mission is to build brands that people love because we believe elevating human connections is Worth Reaching For. It’s worth our dedication, hard work, and calculated risks to anticipate market trends and deliver for our consumers, shareholders, employees, and industry. This dedication is what has driven us to become one of the fastest-growing, large CPG companies in the U.S. at retail, and it drives our pursuit to deliver what’s next.

Every day, people reach for brands from our high-end, imported beer portfolio anchored by the iconic Corona Extra and Modelo Especial, a flavorful lineup of Modelo Cheladas, and favorites like Pacifico, and Victoria; our exceptional wine brands including The Prisoner Wine Company, Robert Mondavi Winery, Kim Crawford, Schrader Cellars, and Lingua Franca; and our craft spirits brands such as Mi CAMPO Tequila and High West Whiskey.

As an agriculture-based company, we strive to operate in a way that is sustainable and responsible. Our ESG strategy is embedded into our business and we focus on serving as good stewards of the environment, investing in our communities, and promoting responsible beverage alcohol consumption. We believe these aspirations in support of our longer-term business strategy allow us to contribute to a future that is truly Worth Reaching For.

To learn more, visit www.cbrands.com and follow us on LinkedIn and Instagram.

A downloadable PDF copy of this news release can be found here. http://ml.globenewswire.com/Resource/Download/aa9376c1-2277-4318-9ebe-c8b3de5c4d47

Digital solution will be designed to help guide users through injection process April 08, 2026 17:00 ET  | Source: Enable Injections, Inc.

CINCINNATI, April 08, 2026 (GLOBE NEWSWIRE) -- Aptar Digital Health, a global leader in digital health solutions enhancing the patient experience, and Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse® On-Body Delivery System, today announced a strategic partnership naming Aptar Digital Health as Enable’s preferred digital health partner for the enFuse® system. This digital solution will be designed to guide patients and caregivers throughout the injection process and help strengthen engagement support before, during and after administration. 

Through this partnership, Aptar Digital Health will deliver a companion digital solution for Enable Injections’ enFuse® system, designed to enhance the patient experience and support adherence. Key features of the solution will include treatment data recording, onboarding and training modules, injection guidance, patient-reported outcomes and symptom tracking - helping to empower patients and caregivers with greater confidence and control over the treatment process. 

Built on a flexible and scalable architecture, the companion solution will be deployed alongside the enFuse® system, enabling pharmaceutical partners to extend the value of their therapies beyond delivery. Designed to evolve across the drug development lifecycle, the solution will support use cases from clinical trials through commercialization, aligned with development and launch strategies.

Adherence data and patient reported outcomes will be captured remotely, securely stored and made available through analytics dashboards that generate actionable insights to support clinical development, launch readiness and real-world use. The modular, program-specific design will allow pharmaceutical partners to integrate digital components into their clinical or commercial programs based on their needs. By combining device-generated data with patient reported insights, the solution will help drive more informed decisions grounded in real-world usage. 

“The enFuse® companion solution reflects our vision of a more connected treatment experience that supports patients beyond the moment of injection,” said Michael D. Hooven, Chairman and CEO of Enable Injections. “Together with Aptar Digital Health, we aim to combine innovative drug delivery with digital support tools that can help patients remain engaged in their therapy and enable healthcare providers to better understand and support each patient’s journey.” 

“We are excited to partner with Enable Injections to help bring the next generation of drug delivery solutions to life,” said Damien McKeon, SVP Strategic Partnerships, Aptar Digital Health. “Large-volume biologic therapies are increasingly used to treat complex chronic conditions. They often require long-term adherence to achieve optimal outcomes. Digital solutions supporting treatment tracking and patient engagement can help address common adherence challenges associated with self-administration.”

About Aptar Digital Health 
Aptar Pharma's Digital Health division is part of AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, including dosing and protection technologies, and consumer product dispensing. Aptar Digital Health creates end-to-end solutions to enhance patient experiences every day, leveraging a holistic ecosystem of digital interventions. Amplified by an industry-leading portfolio of products and solutions, Aptar Digital Health’s offering combines mobile and web apps, Software-as-Medical-Device, connected drug delivery systems, advanced data analysis services, and patient onboarding and training solutions to actively empower patients and create a positive treatment journey. Headquartered in Crystal Lake, Illinois, Aptar employs 14,000 dedicated people across 20 countries. Learn more at www.aptardigitalhealth.com and http://www.aptar.com.

About Enable Injections
Cincinnati-based Enable Injections is a global healthcare innovation company committed to improving the patient treatment experience through the development and manufacturing of the enFuse® on-body drug delivery system. An innovative wearable technology, the enFuse® system is designed to deliver large volumes of pharmaceutical and biologic therapeutics via subcutaneous administration, with the aim of improving convenience, supporting improved outcomes, and advancing healthcare system economics.

Enable is currently working with a number of pharmaceutical partners to conduct clinical trials and plan for the joint commercial launch of their therapies in combination with the enFuse® technology. For more information, visit www.enableinjections.com.

Media Contacts: 
Ciara Jackson 
Aptar Pharma
[email protected]

Robert Haney
Real Chemistry
[email protected]

Wall Street expects a year-over-year decline in earnings on higher revenues when AptarGroup (ATR - Free Report) reports results for the quarter ended March 2026. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.

The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on April 30. On the other hand, if they miss, the stock may move lower.

While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.

Zacks Consensus EstimateThis maker of consumer-product dispensing systems is expected to post quarterly earnings of $1.15 per share in its upcoming report, which represents a year-over-year change of -4.2%.

Revenues are expected to be $964.39 million, up 8.7% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 2.96% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core.

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for AptarGroup?For AptarGroup, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -1.09%.

On the other hand, the stock currently carries a Zacks Rank of #4.

So, this combination makes it difficult to conclusively predict that AptarGroup will beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that AptarGroup would post earnings of $1.24 per share when it actually produced earnings of $1.25, delivering a surprise of +0.81%.

Over the last four quarters, the company has beaten consensus EPS estimates four times.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

AptarGroup doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

Expected Results of an Industry PlayerAnother stock from the Zacks Containers - Paper and Packaging industry, Avery Dennison (AVY - Free Report) , is soon expected to post earnings of $2.41 per share for the quarter ended March 2026. This estimate indicates a year-over-year change of +4.8%. Revenues for the quarter are expected to be $2.27 billion, up 5.7% from the year-ago quarter.

The consensus EPS estimate for Avery Dennison has been revised 0.2% lower over the last 30 days to the current level. However, a lower Most Accurate Estimate has resulted in an Earnings ESP of -0.16%.

When combined with a Zacks Rank of #4 (Sell), this Earnings ESP makes it difficult to conclusively predict that Avery Dennison will beat the consensus EPS estimate. Over the last four quarters, the company surpassed consensus EPS estimates three times.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.

Posted by Defense World Staff on Apr 27th, 2026

Cwm LLC increased its position in shares of AptarGroup, Inc. (NYSE:ATR – Free Report) by 102.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 10,781 shares of the industrial products company’s stock after purchasing an additional 5,457 shares during the quarter. Cwm LLC’s holdings in AptarGroup were worth $1,315,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Azzad Asset Management Inc. ADV bought a new position in shares of AptarGroup in the third quarter valued at approximately $1,383,000. Nordea Investment Management AB bought a new stake in AptarGroup during the fourth quarter worth $7,314,000. First Trust Advisors LP boosted its position in AptarGroup by 218.1% in the third quarter. First Trust Advisors LP now owns 372,369 shares of the industrial products company’s stock worth $49,771,000 after purchasing an additional 255,291 shares during the last quarter. Aptus Capital Advisors LLC boosted its position in AptarGroup by 14.1% in the third quarter. Aptus Capital Advisors LLC now owns 63,238 shares of the industrial products company’s stock worth $8,452,000 after purchasing an additional 7,829 shares during the last quarter. Finally, Assenagon Asset Management S.A. grew its stake in AptarGroup by 390.0% in the 4th quarter. Assenagon Asset Management S.A. now owns 10,276 shares of the industrial products company’s stock valued at $1,253,000 after purchasing an additional 8,179 shares during the period. Hedge funds and other institutional investors own 88.52% of the company’s stock.

Insiders Place Their Bets In other news, insider Gael Touya sold 3,500 shares of AptarGroup stock in a transaction dated Wednesday, February 18th. The shares were sold at an average price of $141.35, for a total value of $494,725.00. Following the completion of the transaction, the insider owned 27,963 shares in the company, valued at $3,952,570.05. This trade represents a 11.12% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 0.73% of the stock is owned by corporate insiders.

Analysts Set New Price Targets Several brokerages have recently issued reports on ATR. KeyCorp reaffirmed an “overweight” rating and set a $220.00 target price on shares of AptarGroup in a research report on Friday, January 9th. Wells Fargo & Company upgraded shares of AptarGroup from an “equal weight” rating to an “overweight” rating and increased their price target for the company from $133.00 to $144.00 in a research report on Friday, March 20th. Weiss Ratings restated a “hold (c)” rating on shares of AptarGroup in a report on Friday, March 27th. Finally, Robert W. Baird set a $156.00 price objective on shares of AptarGroup in a research report on Monday, February 9th. Four equities research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, AptarGroup presently has a consensus rating of “Hold” and an average price target of $173.00.

Check Out Our Latest Report on AptarGroup

AptarGroup Stock Performance NYSE:ATR opened at $124.10 on Monday. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.62 and a quick ratio of 1.16. The business has a fifty day simple moving average of $131.64 and a two-hundred day simple moving average of $126.79. AptarGroup, Inc. has a 1 year low of $103.23 and a 1 year high of $164.28. The company has a market capitalization of $7.91 billion, a P/E ratio of 21.07, a P/E/G ratio of 2.96 and a beta of 0.49.

AptarGroup (NYSE:ATR – Get Free Report) last issued its quarterly earnings results on Thursday, February 5th. The industrial products company reported $1.25 EPS for the quarter, beating analysts’ consensus estimates of $1.24 by $0.01. The firm had revenue of $962.74 million for the quarter, compared to analysts’ expectations of $878.58 million. AptarGroup had a return on equity of 14.25% and a net margin of 10.40%.The business’s revenue for the quarter was up 13.5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.52 EPS. AptarGroup has set its Q1 2026 guidance at 1.130-1.210 EPS. On average, analysts expect that AptarGroup, Inc. will post 5.38 earnings per share for the current year.

AptarGroup declared that its board has authorized a share repurchase plan on Thursday, February 5th that allows the company to repurchase $600.00 million in shares. This repurchase authorization allows the industrial products company to purchase up to 7.1% of its stock through open market purchases. Stock repurchase plans are generally a sign that the company’s management believes its shares are undervalued.

AptarGroup Announces Dividend The firm also recently announced a quarterly dividend, which will be paid on Wednesday, May 27th. Shareholders of record on Wednesday, May 6th will be given a dividend of $0.48 per share. This represents a $1.92 dividend on an annualized basis and a yield of 1.5%. The ex-dividend date is Wednesday, May 6th. AptarGroup’s dividend payout ratio (DPR) is currently 32.60%.

AptarGroup Company Profile (Free Report)

AptarGroup, Inc is a global provider of advanced dispensing, sealing and protection solutions for consumer and pharmaceutical markets. The company designs and manufactures a broad portfolio of products that enable the controlled delivery of liquids, gels, powders and aerosols. Its customer base spans beauty and personal care, home care, food and beverage, and pharmaceutical sectors, where innovation in packaging and drug‐delivery devices drives brand differentiation and regulatory compliance.

In the consumer markets, AptarGroup offers pumps, actuators, valves, closures and specialized bottles engineered for precision, convenience and sustainability.

See Also Five stocks we like better than AptarGroup Want to see what other hedge funds are holding ATR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AptarGroup, Inc. (NYSE:ATR – Free Report).

Receive News & Ratings for AptarGroup Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AptarGroup and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEChicago Partners Investment Group LLC Invests $1.18 Million in Sprott Junior Uranium Miners ETF $URNJ

NEXT HEADLINE »iShares Core MSCI Pacific ETF $IPAC Shares Sold by Cwm LLC

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery and consumer product dispensing, dosing and protection technologies, today reported the following first quarter results for the period ended March 31, 2026, as compared to the corresponding period of the last fiscal year.

First Quarter 2026 Highlights

(Compared to the prior year quarter; see Non-GAAP section for full definitions; see reconciliation for Non-GAAP measures)

Reported sales increased 11% and core sales were flat Reported net income decreased 8% to $73 million and reported earnings per share decreased 4% to $1.12 Adjusted earnings per share were $1.19, a decrease of 8%, compared to the prior year at constant currency Adjusted EBITDA margin was 19.2% compared to 20.7% in the prior year Returned $131 million to shareholders through share repurchases and dividends Gael Touya named Aptar’s next CEO effective September 1, 2026 “Across the broader Pharma portfolio, we continue to see growing demand in key areas including GLP‑1 therapies, biologics, systemic nasal drug delivery, nasal decongestants, ophthalmic dispensing, and active material solutions. As anticipated, first quarter results were impacted by emergency medicine destocking, with comparisons further challenged by the exceptionally strong prior-year quarter for the prescription division. The injectables division delivered another quarter of strong, double-digit growth. Consumer dispensing also contributed positively, with volume growth across Beauty and Closures, supported by robust demand in prestige fragrance and beverage applications,” said Stephan B. Tanda, Aptar President and CEO.

First Quarter Results

For the quarter ended March 31, 2026, reported sales increased 11% to $982.9 million compared to $887.3 million in the prior year period. Core sales were flat compared to the prior year period.

First Quarter Segment Sales Analysis
(Change Over Prior Year)

Pharma

Beauty

Closures

Total AptarGroup

Reported Sales Growth

7%

19%

5%

11%

Currency Effects (1)

(7)%

(9)%

(5)%

(8)%

Acquisitions

(1)%

(7)%

0%

(3)%

Core Sales Growth

(1)%

3%

0%

0%

  (1) - Currency effects are approximated by translating last year's amounts at this year's foreign exchange rates.

Pharma’s reported sales increased 7% when compared to the prior year period, with a currency contribution of 7%. Excluding acquisitions, core sales declined 1% in the quarter when compared to the prior year period. In the prescription division, sales for dispensing systems declined 10% primarily due to reduced sales in the emergency medicine category, as anticipated, while the pipeline for systemic nasal drug delivery continued to build. Consumer healthcare sales increased 4% on strong nasal decongestant and eye care solutions. Sales in the injectables division increased 20%, mainly driven by growth in demand for elastomeric components used for GLP-1, biologics and antithrombotics. Active material science solutions declined 1% due primarily to lower sales for diabetes test strips and probiotics. Adjusted EBITDA margin was 33.3%, a decrease of 150 basis points, reflecting a less favorable product mix, while royalties continued to positively impact margins.

Beauty’s reported sales increased 19% when compared to the prior year period, driven by a 9% benefit from currency changes and a 7% contribution from acquisitions, with core sales growth of 3%. There was increased demand for fragrance dispensing, as well as hair care and body care applications. Adjusted EBITDA margin was 11.1%, a decline of 100 basis points, due to less favorable product mix, primarily in North America and isolated operational disruptions at a supplier as reported last quarter.

Closures’ reported sales rose 5% from the prior year quarter and core sales were flat, with a 5% currency benefit. While product volumes were up, core sales results were negatively impacted by the pass through of lower resin pricing. Adjusted EBITDA margin was 13.1%, a decline of 270 basis points, primarily due to the previously reported maintenance issues, temporary plant closures as a result of extreme weather in North America and certain investment write offs.

Reported first quarter earnings per share were $1.12 compared to $1.17 reported a year ago. Adjusted earnings per share were $1.19, compared to the prior year period’s adjusted earnings per share of $1.30, including comparable exchange rates. The first quarter reported effective tax rate was 22.4% and the adjusted effective tax rate was 22.6%, compared to the prior year period’s reported and adjusted effective tax rates of 25.8%.

Outlook

Regarding Aptar’s outlook, Tanda stated, “Looking ahead to Q2, excluding destocking in emergency medicine within Pharma, we anticipate a solid quarter with growth across each segment. Outside of the emergency medicine end market, our prescription division is expected to return to healthy growth, and we anticipate growth across a number of pharma end markets mainly due to strength in our injectables and consumer healthcare divisions. We also anticipate a strong quarter for Closures and continued growth in Beauty, particularly in fragrance. Heading into the quarter, we remain mindful of potential supply‑chain uncertainties as we continue to operate in a dynamic environment.”

Aptar currently expects adjusted earnings per share for the second quarter of 2026 to be in the range of $1.32 to $1.40. This guidance assumes an effective tax rate range of 22.5% to 24.5%. The earnings per share guidance range is assuming a 1.18 Euro to USD exchange rate.

Cash Dividends and Share Repurchases

As previously announced, Aptar’s Board of Directors approved a quarterly cash dividend of $0.48 per share. The payment date is May 27, 2026, to stockholders of record as of May 6, 2026. During the first quarter, Aptar repurchased 707 thousand shares for $100 million. Aptar may repurchase shares through the open market, privately negotiated transactions or other programs, subject to market conditions.

Open Conference Call

There will be a conference call held on Friday, May 1, 2026 at 8:00 a.m. Central Time to discuss the company’s first quarter results for 2026. The call will last approximately one hour. Interested parties are invited to listen to a live webcast by visiting the Investor Relations website at investors.aptar.com. Replay of the conference call can also be accessed for a limited time on the Investor Relations page of the website.

About Aptar

Aptar is a global leader in drug delivery and consumer product dosing, dispensing and protection technologies. Aptar serves a number of attractive end markets including pharmaceutical, beauty, food, beverage, personal care and home care. Using market expertise, proprietary design, engineering and science to create innovative solutions for many of the world’s leading brands, Aptar in turn makes a meaningful difference in the lives, looks, health and homes of millions of patients and consumers around the world. Aptar is headquartered in Crystal Lake, Illinois and has more than 14,000 dedicated employees in 20 countries. For more information, visit www.aptar.com.

Presentation of Non-GAAP Information

This press release refers to certain non-GAAP financial measures, including current year adjusted earnings per share and adjusted EBITDA, which exclude the impact of restructuring initiatives, acquisition-related costs, certain purchase accounting adjustments related to acquisitions and investments and net unrealized investment gains and losses related to observable market price changes on equity securities, and other special items. Core sales and adjusted earnings per share also neutralize the impact of foreign currency translation effects when comparing current results to the prior year. Adjusted EBITDA is defined as earnings before net interest, taxes, depreciation, amortization, restructuring initiatives, acquisition-related costs, net unrealized investment gains and losses related to observable market price changes on equity securities and other special items. For the quarter ended March 31, 2026, “Other special items” include costs incurred related to non-ordinary-course litigation, specifically: lawsuits between Aptar and ARS Pharmaceuticals, Inc., involving Aptar’s claims of trade-secret misappropriation and contractual breaches and ARS’s lawsuit against Aptar under U.S. antitrust laws; and patent infringement actions filed by Nemera La Verpillière SAS in Germany and France relating to certain of Aptar’s ophthalmic products. These costs are excluded because they do not reflect our core operating performance. Please refer to “Legal Proceedings” within Note 13 - Commitments and Contingencies within Aptar’s Form 10-K for the year ended December 31, 2025 and subsequent SEC filings for more information. Adjusted EBITDA margin is adjusted EBITDA divided by reported net sales. Non-GAAP financial measures may not be comparable to similarly titled non-GAAP financial measures provided by other companies. Aptar’s management believes these non-GAAP financial measures provide useful information to our investors because they allow for a better period over period comparison of operating results by removing the impact of items that, in management’s view, do not reflect Aptar’s core operating performance. These non-GAAP financial measures also provide investors with certain information used by Aptar’s management when making financial and operational decisions. Free cash flow is calculated as cash provided by operating activities less capital expenditures plus proceeds from government grants related to capital expenditures. We believe that it is meaningful to investors in evaluating our financial performance and measuring our ability to generate cash internally to fund our initiatives. These non-GAAP financial measures should not be considered in isolation or as a substitute for GAAP financial results but should be read in conjunction with the unaudited condensed consolidated statements of income and other information presented herein. A reconciliation of non-GAAP financial measures to the most directly comparable GAAP measures is included in the accompanying tables. Our outlook is provided on a non-GAAP basis because certain reconciling items are dependent on future events that either cannot be controlled, such as exchange rates and changes in the fair value of equity investments, or reliably predicted because they are not part of the company's routine activities, such as restructuring, acquisition costs and other special items.

This press release contains forward-looking statements, including certain statements set forth under the “Outlook” section of this press release. Words such as “expects,” “anticipates,” “believes,” “estimates,” “future,” “potential,” “continues” and other similar expressions or future or conditional verbs such as “will,” “should,” “would” and “could” are intended to identify such forward-looking statements. Forward-looking statements are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and are based on our beliefs as well as assumptions made by and information currently available to us. Accordingly, our actual results or other events may differ materially from those expressed or implied in such forward-looking statements due to known or unknown risks and uncertainties that exist in our operations and business environment including, but not limited to: geopolitical conflicts worldwide and the resulting indirect impact on demand from our customers selling their products into these countries, as well as rising input costs and certain supply chain disruptions; cybersecurity threats against our systems and/or service providers that could impact our networks and reporting systems; the availability of raw materials and components (particularly from sole sourced suppliers for some of our Pharma solutions) as well as the financial viability of these suppliers; our ability to protect and defend our intellectual property rights, as well as litigation involving intellectual property rights; the outcome of any legal proceeding that has been or may be instituted against us and others; lower demand and asset utilization due to an economic recession either globally or in key markets we operate within; economic conditions worldwide, including inflationary conditions and potential deflationary conditions in other regions we rely on for growth; competition, including technological advances; significant tariffs and other restrictions on foreign imports imposed by the U.S. and related countermeasures taken by impacted foreign countries; our ability to successfully implement facility expansions and new facility projects; fluctuations in the cost of materials, components, transportation cost as a result of supply chain disruptions and labor shortages, and other input costs; significant fluctuations in foreign currency exchange rates or our effective tax rate; the impact of tax reform legislation, changes in tax rates and other tax-related events or transactions that could impact our effective tax rate; financial conditions of customers and suppliers; consolidations within our customer or supplier bases; changes in customer and/or consumer spending levels; loss of one or more key accounts; our ability to offset inflationary impacts with cost containment, productivity initiatives and price increases; changes in capital availability or cost, including rising interest rates; loss of royalty revenue due to contract expirations; volatility of global credit markets; our ability to identify potential new acquisitions and to successfully acquire and integrate such operations, including the successful integration of the businesses we have acquired; our ability to build out acquired businesses and integrate the product/service offerings of the acquired entities into our existing product/service portfolio; direct or indirect consequences of acts of war, terrorism or social unrest; the impact of natural disasters and other weather-related occurrences; fiscal and monetary policies and other regulations; changes, difficulties or failures in complying with government regulation, including FDA or similar foreign governmental authorities; changing regulations or market conditions regarding environmental sustainability; our ability to retain key members of management and manage labor costs; work stoppages due to labor disputes; our ability to meet future cash flow estimates to support our goodwill impairment testing; the demand for existing and new products; the success of our customers’ products, particularly in the pharmaceutical industry; our ability to manage worldwide customer launches of complex technical products, particularly in developing markets; difficulties in product development and uncertainties related to the timing or outcome of product development; significant product liability claims; and other risks associated with our operations. For additional information on these and other risks and uncertainties, please see our filings with the Securities and Exchange Commission, including the discussion under “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Form 10-K and Form 10-Qs. We undertake no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

AptarGroup, Inc.

Condensed Consolidated Financial Statements (Unaudited)

(In Thousands, Except Per Share Data)

Consolidated Statements of Income

  Three Months Ended

March 31,

2026

2025

Net Sales

$

982,868

$

887,305

Cost of Sales (exclusive of depreciation and amortization shown below)

630,959

550,891

Selling, Research & Development and Administrative

167,602

155,277

Depreciation and Amortization

75,725

65,647

Restructuring Initiatives

1,086

2,042

Operating Income

107,496

113,448

Other Income (Expense):

Interest Expense

(16,942

)

(11,351

)

Interest Income

3,642

2,814

Net Investment Loss

(1,086

)

(1,096

)

Equity in Results of Affiliates

714

2,086

Miscellaneous (Expense) Income, net

(53

)

114

Income before Income Taxes

93,771

106,015

Provision for Income Taxes

21,004

27,352

Net Income

$

72,767

$

78,663

Net (Income) Loss Attributable to Noncontrolling Interests

(4

)

135

Net Income Attributable to Redeemable Noncontrolling Interests

(89

)

—

Net Income Attributable to AptarGroup, Inc.

$

72,674

$

78,798

Net Income Attributable to AptarGroup, Inc. per Common Share:

Basic

$

1.13

$

1.19

Diluted

$

1.12

$

1.17

Average Numbers of Shares Outstanding:

Basic

64,050

66,271

Diluted

64,834

67,491

AptarGroup, Inc.

Condensed Consolidated Financial Statements (Unaudited)

(continued)

($ In Thousands)

Consolidated Balance Sheets

  March 31,
2026

December 31,
2025

ASSETS

Cash and Equivalents

$

222,529

$

402,424

Short-term Investments

6,948

7,109

Accounts and Notes Receivable, Net

833,268

803,830

Inventories

551,482

537,845

Prepaid and Other

154,045

142,354

Total Current Assets

1,768,272

1,893,562

Property, Plant and Equipment, Net

1,660,929

1,676,479

Goodwill

1,072,560

1,077,898

Other Assets

596,022

604,780

Total Assets

$

5,097,783

$

5,252,719

LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS’ EQUITY

Short-Term Obligations

$

222,166

$

343,531

Accounts Payable, Accrued and Other Liabilities

840,867

822,913

Total Current Liabilities

1,063,033

1,166,444

Long-Term Obligations

1,143,370

1,139,433

Deferred Liabilities and Other

217,129

234,617

Total Liabilities

2,423,532

2,540,494

Redeemable Noncontrolling Interests

26,694

26,244

Total Mezzanine Equity

26,694

26,244

AptarGroup, Inc. Stockholders' Equity

2,629,495

2,668,096

Noncontrolling Interests in Subsidiaries

18,062

17,885

Total Stockholders' Equity

2,647,557

2,685,981

Total Liabilities, Mezzanine Equity and Stockholders' Equity

$

5,097,783

$

5,252,719

AptarGroup, Inc.

Condensed Consolidated Financial Statements (Unaudited)

(continued)

($ In Thousands)

Consolidated Statement of Cash Flows

Three Months Ended March 31,

2026

2025

Cash Flows from Operating Activities:

​

​

Net income

$

72,767

$

78,663

Adjustments to reconcile net income to net cash provided by operations:

Depreciation

64,310

54,903

Amortization

11,415

10,744

Stock-based compensation

16,764

19,193

Provision for CECL

644

35

Loss (gain) on disposition of fixed assets

81

(271

)

Net loss on remeasurement of equity securities

1,086

1,096

Deferred income taxes

(4,567

)

(1,860

)

Defined benefit plan expense

3,443

3,277

Equity in results of affiliates

(714

)

(2,086

)

Impairment loss

901

—

Changes in balance sheet items, excluding effects from foreign currency adjustments:

Accounts and other receivables

(33,030

)

(69,247

)

Inventories

(16,943

)

(6,043

)

Prepaid and other current assets

(12,393

)

(12,617

)

Accounts payable, accrued and other liabilities

36,422

33,324

Income taxes payable

103

(7,195

)

Retirement and deferred compensation plan

(15,271

)

(11,751

)

Other changes, net

(6,324

)

(7,423

)

Net Cash Provided by Operations

118,694

82,742

Cash Flows from Investing Activities:

Capital expenditures

(65,396

)

(56,862

)

Proceeds from sale of property, plant and equipment

1,327

79

Purchases of short-term investments, net

(103

)

(88

)

Acquisition of intangible assets, net

(592

)

(2,475

)

Notes receivable, net

(335

)

2,714

Net Cash Used by Investing Activities

(65,099

)

(56,632

)

Cash Flows from Financing Activities:

Proceeds from notes payable and overdrafts

2,930

79

Repayments of notes payable and overdrafts

(2,895

)

—

Proceeds and (repayments) of short term revolving credit facility, net

7,000

(23,880

)

Proceeds from long-term obligations

5,037

124

Repayments of long-term obligations

(127,927

)

(4,552

)

Payment of contingent consideration obligation

(2,197

)

—

Dividends paid

(30,920

)

(29,923

)

Proceeds from stock option exercises

18,516

3,375

Purchase of treasury stock

(99,973

)

(80,000

)

Redeemable noncontrolling interest

89

—

Net Cash Used by Financing Activities

(230,340

)

(134,777

)

Effect of Exchange Rate Changes on Cash

(3,150

)

10,662

Net Decrease in Cash and Equivalents and Restricted Cash

(179,895

)

(98,005

)

Cash and Equivalents and Restricted Cash at Beginning of Period

404,849

223,844

Cash and Equivalents and Restricted Cash at End of Period

$

224,954

$

125,839

AptarGroup, Inc.

Reconciliation of Adjusted EBIT and Adjusted EBITDA to Net Income (Unaudited)

($ In Thousands)

  Three Months Ended
March 31, 2026

Consolidated

Pharma

Beauty

Closures

Corporate

& Other

Net Interest

Net Sales

$

982,868

$

438,560

$

363,635

$

180,673

$

—

$

—

Reported net income

$

72,767

Reported income taxes

21,004

Reported income before income taxes

93,771

106,658

14,458

9,184

(23,229

)

(13,300

)

Adjustments:

Restructuring initiatives

1,086

5

1,301

249

(469

)

Net investment loss

1,086

—

—

—

1,086

Transaction costs related to acquisitions

45

45

—

—

—

Purchase accounting adjustments related to acquisitions and investments

145

145

—

—

—

Other special items

3,727

3,727

—

—

—

Adjusted earnings before income taxes

99,860

110,580

15,759

9,433

(22,612

)

(13,300

)

Interest expense

16,942

16,942

Interest income

(3,642

)

(3,642

)

Adjusted earnings before net interest and taxes (Adjusted EBIT)

113,160

110,580

15,759

9,433

(22,612

)

—

Depreciation and amortization

75,725

35,643

24,723

14,224

1,135

Adjusted earnings before net interest, taxes, depreciation and amortization (Adjusted EBITDA)

$

188,885

$

146,223

$

40,482

$

23,657

$

(21,477

)

$

—

Reported net income margins (Reported net income / Reported Net Sales)

7.4

%

Adjusted EBITDA margins (Adjusted EBITDA / Reported Net Sales)

19.2

%

33.3

%

11.1

%

13.1

%

Three Months Ended
March 31, 2025

Consolidated

Pharma

Beauty

Closures

Corporate

& Other

Net Interest

Net Sales

$

887,305

$

409,467

$

305,707

$

172,131

$

—

$

—

Reported net income

$

78,663

Reported income taxes

27,352

Reported income before income taxes

106,015

111,112

16,681

12,333

(25,574

)

(8,537

)

Adjustments:

Restructuring initiatives

2,042

190

395

1,352

105

Net investment loss

1,096

—

—

—

1,096

Adjusted earnings before income taxes

109,153

111,302

17,076

13,685

(24,373

)

(8,537

)

Interest expense

11,351

11,351

Interest income

(2,814

)

(2,814

)

Adjusted earnings before net interest and taxes (Adjusted EBIT)

117,690

111,302

17,076

13,685

(24,373

)

—

Depreciation and amortization

65,647

31,148

20,062

13,575

862

—

Adjusted earnings before net interest, taxes, depreciation and amortization (Adjusted EBITDA)

$

183,337

$

142,450

$

37,138

$

27,260

$

(23,511

)

$

—

Reported net income margins (Reported net income / Reported Net Sales)

8.9

%

Adjusted EBITDA margins (Adjusted EBITDA / Reported Net Sales)

20.7

%

34.8

%

12.1

%

15.8

%

AptarGroup, Inc.

Reconciliation of Adjusted Earnings Per Diluted Share (Unaudited)

(In Thousands, Except Per Share Data)

  Three Months Ended
March 31,

2026

2025

Income before Income Taxes

$

93,771

$

106,015

Adjustments:

Restructuring initiatives

1,086

2,042

Net investment loss

1,086

1,096

Transaction costs related to acquisitions

45

—

Purchase accounting adjustments related to acquisitions and investments

145

—

Other special items

3,727

—

Foreign currency effects (1)

8,992

Adjusted Earnings before Income Taxes

$

99,860

$

118,145

Provision for Income Taxes

$

21,004

$

27,352

Adjustments:

Restructuring initiatives

279

506

Net investment loss

266

269

Transaction costs related to acquisitions

11

—

Purchase accounting adjustments related to acquisitions and investments

49

—

Other special items

953

—

Foreign currency effects (1)

2,320

Adjusted Provision for Income Taxes

$

22,562

$

30,447

Net (Income) Loss Attributable to Noncontrolling Interests

$

(4

)

$

135

Net Income Attributable to Redeemable Noncontrolling Interests

$

(89

)

$

—

Net Income Attributable to AptarGroup, Inc.

$

72,674

$

78,798

Adjustments:

Restructuring initiatives

807

1,536

Net investment loss

820

827

Transaction costs related to acquisitions

34

—

Purchase accounting adjustments related to acquisitions and investments

96

—

Other special items

2,774

—

Foreign currency effects (1)

6,672

Adjusted Net Income Attributable to AptarGroup, Inc.

$

77,205

$

87,833

Average Number of Diluted Shares Outstanding

64,834

67,491

Net Income Attributable to AptarGroup, Inc. Per Diluted Share

$

1.12

$

1.17

Adjustments:

Restructuring initiatives

0.01

0.02

Net investment loss

0.01

0.01

Transaction costs related to acquisitions

—

—

Purchase accounting adjustments related to acquisitions and investments

—

—

Other special items

0.05

—

Foreign currency effects (1)

0.10

Adjusted Net Income Attributable to AptarGroup, Inc. Per Diluted Share

$

1.19

$

1.30

  (1) Foreign currency effects are approximations of the adjustment necessary to state the prior year earnings and earnings per share using current period foreign currency exchange rates.

AptarGroup, Inc.

Reconciliation of Free Cash Flow to Net Cash Provided by Operations (Unaudited)

(In Thousands)

  Three Months Ended
March 31,

2026

2025

Net Cash Provided by Operations

$

118,694

$

82,742

Capital Expenditures

(65,396

)

(56,862

)

Free Cash Flow

$

53,298

$

25,880

AptarGroup, Inc.

Reconciliation of Adjusted Earnings Per Diluted Share (Unaudited)

(In Thousands, Except Per Share Data)

  Three Months Ending
June 30,

Expected 2026

2025

Income before Income Taxes

$

139,714

Adjustments:

Restructuring initiatives

1,579

Net investment gain

(2,102

)

Transaction costs related to acquisitions

344

Foreign currency effects (1)

919

Adjusted Earnings before Income Taxes

$

140,454

Provision for Income Taxes

$

27,982

Adjustments:

Restructuring initiatives

421

Net investment gain

(515

)

Transaction costs related to acquisitions

86

Foreign currency effects (1)

184

Adjusted Provision for Income Taxes

$

28,158

Net Income Attributable to Noncontrolling Interests

$

(12

)

Net Income Attributable to AptarGroup, Inc.

$

111,720

Adjustments:

Restructuring initiatives

1,158

Net investment gain

(1,587

)

Transaction costs related to acquisitions

258

Foreign currency effects (1)

735

Adjusted Net Income Attributable to AptarGroup, Inc.

$

112,284

Average Number of Diluted Shares Outstanding

67,048

Net Income Attributable to AptarGroup, Inc. Per Diluted Share (3)

$

1.67

Adjustments:

Restructuring initiatives

0.02

Net investment gain

(0.03

)

Transaction costs related to acquisitions

—

Foreign currency effects (1)

0.01

Adjusted Net Income Attributable to AptarGroup, Inc. Per Diluted Share (2)

$1.32 - $1.40

$

1.67

  (1) Foreign currency effects are approximations of the adjustment necessary to state the prior year earnings and earnings per share using current spot rates for all applicable foreign currency exchange rates.

(2) AptarGroup’s expected adjusted earnings per share range for the second quarter of 2026, see non-GAAP section for full definition, is based on an effective tax rate range of 22.5% to 24.5%. This tax rate range compares to our second quarter of 2025 effective tax rate of 20.0% on both reported and adjusted earnings per share. More News From AptarGroup, Inc.

AptarGroup, Inc. (ATR) Q1 2026 Earnings Call Transcript

PENSACOLA, Fla., May 04, 2026 (GLOBE NEWSWIRE) -- Advanced Technology Recycling (ATR), a leading IT Asset Management and Electronics Refurbishment company, is pleased to announce that we are now offering wholesale electronics to the general public through our online auction site. 

The newly rebuilt platform will offer bidding opportunities for personal and commercial buyers at all levels. Bidders will have access to millions of dollars' worth of refurbished electronics, including, but not limited to, computers, phones, servers, RAM, and other devices certified under the R2v3 Ready-for-Resale renewal process.

Buying through our new auction site gives customers direct access to ATR’s Renewed in America products: quality electronics renewed through trusted U.S. facilities that support responsible reuse and help keep valuable technology out of landfills. Every purchase helps advance sustainability while supporting American refurbishment, logistics, ecommerce, and technical jobs across ATR’s nationwide operations.

ATR also offers premium products through ATRStore.com, where customers can shop new-in-box items, Grade-A products, and a wide range of accessories at discounted rates. For buyers searching for hard-to-find items, specialty electronics, and collectibles, ATR also makes unique inventory and discounted electronics available through our three eBay stores. Together, these platforms give customers more ways to purchase virtually any electronic or technological device, in quantities that meet their individual needs, at discounted prices.

The R2 Ready for Resale renewal process ensures each product is carefully received, evaluated, tested, data-sanitized when applicable, and prepared for its next user through a responsible reuse channel. Items that meet resale standards are thoroughly tested, verified for functionality, and listed with clear condition details, giving customers confidence in exactly what they are purchasing. This process helps extend the useful life of quality electronics, so renewed products should absolutely be considered a smart, reliable, and sustainable purchase option.

“ATR’s auction site gives you a smarter way to save money on renewed products while creating U.S jobs, reducing electronic waste, and buying directly from a trusted source,” said Matthew Beer, eCommerce Manager for ATR

Getting started is simple and non-invasive: customers only need to register to bid, then can securely browse products, place bids, receive winning notifications, and initiate checkout processes through the site. We will not spam customers or abuse their contact information; account details are used to support a safe auction experience, purchase communication, billing, and secure order management. The platform is built around familiar auction and ecommerce features, including registered bidding, product photos and descriptions, private questions, winning notifications, billing entry, checkout, and supported payment processing.

“ATR makes it easy for new customers to sell equipment that does not require guaranteed destruction or line-by-line asset management reporting, offering a streamlined path for responsible recovery and resale. We welcome the opportunity to review what you have available, provide a competitive bid, and discuss practical equipment lifecycle solutions tailored to your needs. Interested parties looking to sell equipment to ATR can contact us at [email protected],” said Brodie Ehresman, Director of Marketing.

Visit ATRauctions.com today to start bidding on quality Renewed in America products that help you save money while supporting the reuse of sustainable technology. Organizations with surplus equipment can trust ATR for practical ITAD and Value Recovery solutions designed to maximize returns and extend the life of usable technology. To learn more, search Advanced Technology Recycling on Google and connect with a trusted leader in responsible electronics recovery.

About ATR

ATR is a certified woman-owned company and a nationally recognized leader in electronics recycling and IT asset management, proudly headquartered in Pensacola, FL. As an R2v3/RIOS certified company, ATR upholds the highest standards of environmental sustainability, data security, and responsible recycling. We are approved by the U.S. State Department for ITAR (International Traffic in Arms Regulations) disposal programs and offer GSA (General Services Administration) discounts to all federal agencies. With a deep commitment to providing comprehensive life cycle management services, ATR has built a reputation as an industry leader, delivering the most robust and trusted service portfolio in the market.

3 hours ago

CocaCola (NYSE:KO) EVP Jennifer Mann Sells 23,984 SharesMarketBeat

CocaCola Company (The) (NYSE:KO - Get Free Report) EVP Jennifer Mann sold 23,984 shares of the firm's stock in a transaction dated Wednesday, June 10th. The stock was sold at an average price of $83.41, for a total value of $2,000,505.44. Following the completion of the transaction, the executive vice president owned 157,400 shares of the company's stock, valued at approximately $13,128,734. The trade was a 13.22% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

NYSE:KO

Read CocaCola (NYSE:KO) EVP Jennifer Mann Sells 23,984 Shares

3 hours ago

Dutch Bros (NYSE:BROS) Major Shareholder Sells $15,759,829.98 in StockMarketBeat

Dutch Bros Inc. (NYSE:BROS - Get Free Report) major shareholder Dm Individual Aggregator, Llc sold 261,054 shares of the company's stock in a transaction dated Wednesday, June 10th. The stock was sold at an average price of $60.37, for a total transaction of $15,759,829.98. Following the completion of the sale, the insider owned 2,671,855 shares in the company, valued at $161,299,886.35. This represents a 8.90% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Large shareholders that own at least 10% of a company's shares are required to disclose their transactions with the SEC.

NYSE:BROS

Read Dutch Bros (NYSE:BROS) Major Shareholder Sells $15,759,829.98 in Stock

3 hours ago

Insider Selling: Dutch Bros (NYSE:BROS) Major Shareholder Sells 261,055 Shares of StockMarketBeat

Dutch Bros Inc. (NYSE:BROS - Get Free Report) major shareholder Dm Individual Aggregator, Llc sold 261,055 shares of the business's stock in a transaction dated Thursday, June 11th. The stock was sold at an average price of $63.02, for a total value of $16,451,686.10. Following the completion of the transaction, the insider owned 2,410,800 shares in the company, valued at approximately $151,928,616. This trade represents a 9.77% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Large shareholders that own at least 10% of a company's shares are required to disclose their transactions with the SEC.

NYSE:BROS

Read Insider Selling: Dutch Bros (NYSE:BROS) Major Shareholder Sells 261,055 Shares of Stock

3 hours ago

Travis Boersma Sells 749,999 Shares of Dutch Bros (NYSE:BROS) StockMarketBeat

Dutch Bros Inc. (NYSE:BROS - Get Free Report) Chairman Travis Boersma sold 749,999 shares of Dutch Bros stock in a transaction that occurred on Wednesday, June 10th. The stock was sold at an average price of $60.39, for a total transaction of $45,292,439.61. Following the completion of the sale, the chairman owned 2,671,855 shares of the company's stock, valued at $161,353,323.45. This represents a 21.92% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

NYSE:BROS

Read Travis Boersma Sells 749,999 Shares of Dutch Bros (NYSE:BROS) Stock

3 hours ago

Insider Selling: Dutch Bros (NYSE:BROS) Chairman Sells 750,000 Shares of StockMarketBeat

Dutch Bros Inc. (NYSE:BROS - Get Free Report) Chairman Travis Boersma sold 750,000 shares of the company's stock in a transaction that occurred on Thursday, June 11th. The shares were sold at an average price of $63.02, for a total value of $47,265,000.00. Following the sale, the chairman owned 2,410,800 shares in the company, valued at approximately $151,928,616. This trade represents a 23.73% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

NYSE:BROS

Read Insider Selling: Dutch Bros (NYSE:BROS) Chairman Sells 750,000 Shares of Stock

Sort By

Time Frame

Alert Type

Keywords

Page 1 of 324

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, was named a CDP Supplier Engagement Leader, for the sixth consecutive year. This assessment, based on information reported within the 2025 CDP reporting cycle, highlights companies that are engaging their suppliers on climate change and supporting efforts to address emissions throughout the value chain.

By evaluating supplier engagement and recognizing best practices, CDP aims to accelerate global action on supply chain emissions and the transition towards a more sustainable economy. Aptar received an ‘A’ score on the Supplier Engagement Assessment (SEA), which is in the leadership band. As part of Aptar’s global sustainability strategy, the Company is working to cultivate a supply chain that is both socially inclusive and environmentally conscious, in support of customer and consumer needs.

In recent years, Aptar has continued to work with suppliers to support emission-reduction efforts aligned with its validated science-based targets and Carbon Transition Plan. More than 90% of Aptar’s total emissions are Scope 3 emissions, with over 80% of these linked to purchased goods and services, primarily raw materials such as plastics. For this reason, Aptar collaborates with suppliers, particularly those providing raw materials, to identify potential lower-carbon alternatives and advance circularity through product design and material selection.

Aptar’s Purchasing teams engage suppliers through both one-on-one collaboration and structured forums such as the Aptar Global Supplier Summit. The 2026 summit further strengthened collaboration through targeted challenge briefs, innovation exchanges, and dedicated working sessions that connected suppliers with Aptar teams to address operational and sustainability priorities. These interactions are designed to support alignment with Aptar’s sustainability strategy while advancing practical, supplier-led solutions. In parallel, Aptar continues to strengthen expectations for supplier performance and transparency. Aptar’s expectations of suppliers include sharing environmental data, participating in assessments and screening programs, and contributing to initiatives focused on materials, emissions reduction, and responsible sourcing.

The Supplier Engagement Assessment methodology provides a score which assesses supplier action as reported by a company’s CDP response. The score assesses the level of detail and comprehensiveness of the content, as well as the company’s awareness of climate change issues, management methods and progress towards action taken on climate change as reported in the response. The highest-rated companies are recognized as Supplier Engagement Leaders on the CDP website. For more information on Aptar’s sustainability progress, including its responsible supply chain efforts, visit aptar.com/sustainability.

About Aptar

Aptar is a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing. Aptar partners with the world’s top healthcare and consumer brands to deliver medicines and create exceptional user experiences. Serving diverse markets, from pharmaceutical to beauty to food and beverage, Aptar combines market expertise with proprietary design, engineering and science to develop innovative solutions that help improve lives worldwide. Headquartered in Crystal Lake, Illinois, Aptar employs 14,000 dedicated people across 20 countries. Learn more at http://www.aptar.com.

This press release contains forward-looking statements, including statements regarding Aptar’s sustainability strategy, supplier engagement and collaboration, emissions-reduction efforts, science-based targets and Carbon Transition Plan, and related expectations regarding lower-carbon alternatives, circularity, supplier performance and transparency. Forward-looking statements generally can be identified by the fact that they do not relate strictly to historical or current facts and by use of words such as “expects,” “anticipates,” “believes,” “estimates,” “future,” “potential,” “continues,” “working,” “support,” “advance” and other similar expressions, or future or conditional verbs such as “will,” “should,” “would” and “could,” which are intended to identify such forward-looking statements. Forward-looking statements are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and are based on our beliefs as well as assumptions made by and information currently available to us. Accordingly, our actual results or other events may differ materially from those expressed or implied in such forward-looking statements due to known or unknown risks and uncertainties that exist in our operations and business environment including, but not limited to: supplier participation, performance, transparency and data availability and accuracy; availability, cost and performance of lower-carbon materials, recycled materials and other alternatives; customer and consumer preferences; product performance, quality or supply chain matters; the regulatory environment, including laws, regulations, standards and reporting requirements relating to climate, emissions and sustainability matters; and competition, including technological advances. For additional information on these and other risks and uncertainties, please see our filings with the Securities and Exchange Commission, including the discussion under “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Form 10-K and Form 10-Qs. We undertake no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

More News From AptarGroup, Inc.

On June 09, 2026, AptarGroup Inc ATR shares rose 3.5% today, currently priced at $115.90. The stock has experienced a 52-week range of $103.23 to $164.28, reflecting notable price volatility over the past year.

GF Value™ verdict: Current price of $115.90 is 26.0% below the GF Value™ of $156.52, indicating a potential upside.GF Score™ of 82/100 suggests a strong overall performance relative to peers.Most notable signal: Insiders sold $1.0 million worth of shares in the past three months, showing no buying activity. Is ATR Overvalued or Undervalued? AptarGroup Inc's current trading price of $115.90 is significantly below the GF Value™ of $156.52, indicating that the stock is undervalued by approximately 26.0%. This gap presents a margin of safety for potential investors, as the stock is trading well below its intrinsic value as calculated by GuruFocus. The GF Valuation label of "Modestly Undervalued" supports the notion that there is an opportunity for price appreciation if the market corrects itself in favor of AptarGroup's fundamental value. GF Value™ is GuruFocus' proprietary measure of intrinsic value, calculated from historical trading multiples, past business growth, and future performance estimates.

While the undervaluation presents a favorable opportunity, it is important to consider the broader market conditions and the recent performance trends of the stock. Although AptarGroup's shares have seen a short-term uptick, its year-to-date performance remains at -4.2%, and the one-year decline is substantial at -22.4%. These factors suggest caution as the market assesses both potential recovery and inherent risks.

How Does ATR's Valuation Compare to Its History? MetricCurrentHistorical P/E (TTM)19.9x30.9x Forward P/E21.0xN/A The current P/E (TTM) of 19.9x is significantly lower than its 5-year median of 30.9x, indicating that the stock is trading at a discount relative to its historical valuation. This analysis is consistent with the GF Value™ verdict, reinforcing the view that AptarGroup's shares are undervalued. The forward P/E of 21.0x also suggests that the market expects some improvement in earnings, although current valuations remain attractive relative to historical averages.

What Does ATR's GF Score™ Tell Us? MetricRating GF Score™82/100 Financial Strength6/10 Profitability8/10 Growth9/10 Valuation8/10 Momentum2/10 The GF Score™ of 82/100 indicates that AptarGroup Inc has a strong overall performance, with notable strengths in Growth (9/10) and Profitability (8/10). However, the Momentum score of 2/10 is a concern, as it reflects poor recent price performance, which may deter some investors. The Financial Strength rating of 6/10 suggests a stable but not overly robust financial position, warranting attention in terms of risk management and future growth potential.

What Are Insiders Doing with ATR Stock? In recent months, insider activity has reflected a bearish sentiment, with insiders selling $1.0 million worth of shares and no buying activity reported. This pattern may indicate a lack of confidence among management regarding the near-term prospects for the company. While insider selling does not inherently predict negative outcomes, it can be a signal for potential investors to exercise caution and consider the broader market context.

What This Means for Investors Based on the GF Value™ assessment, AptarGroup Inc appears to be undervalued at its current price of $115.90, presenting a potential opportunity for investors willing to look beyond recent price volatility and insider selling activity.

For the complete analysis, visit the AptarGroup Inc ATR stock page. You can also explore the GF Value™ page for detailed valuation methodology, or use the GuruFocus Stock Screener to find similar opportunities.

Frequently Asked Questions What is ATR's GF Score™?

ATR's GF Score™ is 82/100, indicating strong overall performance compared to peers and a favorable outlook for long-term returns.

Is ATR overvalued or undervalued?

ATR is currently undervalued, with a GF Value™ of $156.52 and a current price of $115.90, suggesting a 26.0% upside potential.

What is ATR's P/E ratio?

ATR's P/E (TTM) is 19.9x, which is significantly below its 5-year median of 30.9x, indicating that the stock is trading at a discount relative to its historical valuation.

This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].

Southwest Gas rides on customer growth, rate gains and a $6.3B investment plan to drive long-term earnings, though pipeline risks and near-term stock lag persist.

Southwest Gas Corporation (NYSE: SWX - Get Free Report) was the target of a significant increase in short interest during the month of March. As of March 13th, there was short interest totaling 1,277,877 shares, an increase of 21.3% from the February 26th total of 1,053,173 shares. Currently, 1.8% of the shares of the stock are

Posted by Defense World Staff on Apr 19th, 2026

Bayforest Capital Ltd grew its stake in shares of Southwest Gas Corporation (NYSE:SWX – Free Report) by 177.3% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 11,103 shares of the utilities provider’s stock after buying an additional 7,099 shares during the quarter. Southwest Gas makes up 0.7% of Bayforest Capital Ltd’s holdings, making the stock its biggest holding. Bayforest Capital Ltd’s holdings in Southwest Gas were worth $888,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Spirit of America Management Corp NY grew its stake in shares of Southwest Gas by 21.7% in the fourth quarter. Spirit of America Management Corp NY now owns 4,200 shares of the utilities provider’s stock worth $336,000 after purchasing an additional 750 shares during the last quarter. Allspring Global Investments Holdings LLC grew its stake in shares of Southwest Gas by 13.8% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 4,348 shares of the utilities provider’s stock worth $348,000 after purchasing an additional 528 shares during the last quarter. SG Americas Securities LLC grew its stake in shares of Southwest Gas by 74.9% in the fourth quarter. SG Americas Securities LLC now owns 9,300 shares of the utilities provider’s stock worth $744,000 after purchasing an additional 3,984 shares during the last quarter. O Keefe Stevens Advisory Inc. grew its stake in shares of Southwest Gas by 7.3% in the fourth quarter. O Keefe Stevens Advisory Inc. now owns 20,048 shares of the utilities provider’s stock worth $1,604,000 after purchasing an additional 1,370 shares during the last quarter. Finally, Wealth Enhancement Advisory Services LLC grew its stake in shares of Southwest Gas by 20.4% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 7,745 shares of the utilities provider’s stock worth $627,000 after purchasing an additional 1,314 shares during the last quarter. Institutional investors own 92.77% of the company’s stock.

Analyst Upgrades and Downgrades Several analysts recently weighed in on SWX shares. Wall Street Zen cut shares of Southwest Gas from a “hold” rating to a “sell” rating in a research note on Saturday. Citigroup raised shares of Southwest Gas from a “neutral” rating to a “buy” rating and boosted their price objective for the stock from $82.00 to $99.00 in a research note on Thursday, January 15th. Mizuho set a $96.00 price objective on shares of Southwest Gas in a research note on Wednesday, February 11th. Finally, Weiss Ratings reissued a “buy (b)” rating on shares of Southwest Gas in a research note on Monday, December 29th. One research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Southwest Gas presently has a consensus rating of “Moderate Buy” and an average target price of $88.40.

Check Out Our Latest Research Report on Southwest Gas

Southwest Gas Price Performance SWX stock opened at $91.06 on Friday. The firm has a market cap of $6.59 billion, a price-to-earnings ratio of 13.86, a PEG ratio of 2.34 and a beta of 0.60. The company has a quick ratio of 1.18, a current ratio of 1.28 and a debt-to-equity ratio of 0.87. Southwest Gas Corporation has a 12-month low of $66.93 and a 12-month high of $93.44. The company’s fifty day simple moving average is $87.95 and its 200 day simple moving average is $83.36.

Southwest Gas (NYSE:SWX – Get Free Report) last released its earnings results on Wednesday, February 25th. The utilities provider reported $1.36 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.40 by ($0.04). The firm had revenue of $480.74 million during the quarter, compared to analyst estimates of $587.01 million. Southwest Gas had a net margin of 14.77% and a return on equity of 6.62%. Southwest Gas’s quarterly revenue was down 13.1% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.39 EPS. Southwest Gas has set its FY 2026 guidance at 4.170-4.320 EPS. On average, analysts expect that Southwest Gas Corporation will post 3.03 earnings per share for the current year.

Southwest Gas Increases Dividend The company also recently announced a quarterly dividend, which will be paid on Monday, June 1st. Investors of record on Friday, May 15th will be issued a $0.645 dividend. The ex-dividend date is Friday, May 15th. This is a positive change from Southwest Gas’s previous quarterly dividend of $0.62. This represents a $2.58 annualized dividend and a yield of 2.8%. Southwest Gas’s dividend payout ratio (DPR) is presently 37.75%.

Southwest Gas Company Profile (Free Report)

Southwest Gas Corporation (NYSE: SWX) is a publicly traded natural gas utility that provides regulated gas distribution services to residential, commercial, industrial and electric generation customers. The company’s core activities include the transportation, distribution and sale of natural gas through an extensive network of pipelines, service lines and metering facilities. Southwest Gas also offers related services such as system maintenance, pipeline safety inspections, emergency response and line extensions to support customer growth and ensure reliable gas delivery.

Founded in 1931 in southern Nevada, Southwest Gas has grown through strategic acquisitions and organic expansion to become one of the nation’s larger natural gas utilities by customer count.

Featured Stories Five stocks we like better than Southwest Gas Want to see what other hedge funds are holding SWX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Southwest Gas Corporation (NYSE:SWX – Free Report).

Receive News & Ratings for Southwest Gas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Southwest Gas and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEDream Finders Homes (NYSE:DFH) Shares Up 10.5% – Time to Buy?

NEXT HEADLINE »Bayforest Capital Ltd Acquires Shares of 13,420 Intel Corporation $INTC

Spire (SR - Free Report) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2026. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.

The earnings report, which is expected to be released on May 6, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.

While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.

Zacks Consensus EstimateThis natural gas distributor is expected to post quarterly earnings of $3.78 per share in its upcoming report, which represents a year-over-year change of +5%.

Revenues are expected to be $1.11 billion, up 5.2% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 61.36% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core.

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for Spire?For Spire, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -1.59%.

On the other hand, the stock currently carries a Zacks Rank of #3.

So, this combination makes it difficult to conclusively predict that Spire will beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that Spire would post earnings of $1.62 per share when it actually produced earnings of $1.77, delivering a surprise of +9.26%.

Over the last four quarters, the company has beaten consensus EPS estimates two times.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

Spire doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

Expected Results of an Industry PlayerAnother stock from the Zacks Utility - Gas Distribution industry, Southwest Gas (SWX - Free Report) , is soon expected to post earnings of $1.88 per share for the quarter ended March 2026. This estimate indicates a year-over-year change of +13.9%. Revenues for the quarter are expected to be $737 million, down 43.2% from the year-ago quarter.

Over the last 30 days, the consensus EPS estimate for Southwest Gas has been revised 5.8% up to the current level. Nevertheless, the company now has an Earnings ESP of 0.00%, reflecting an equal Most Accurate Estimate.

This Earnings ESP, combined with its Zacks Rank #3 (Hold), makes it difficult to conclusively predict that Southwest Gas will beat the consensus EPS estimate. Over the last four quarters, the company surpassed consensus EPS estimates two times.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.

Southwest Gas (SWX - Free Report) came out with quarterly earnings of $1.91 per share, beating the Zacks Consensus Estimate of $1.88 per share. This compares to earnings of $1.65 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +1.60%. A quarter ago, it was expected that this natural gas company would post earnings of $1.4 per share when it actually produced earnings of $1.36, delivering a surprise of -2.86%.

Over the last four quarters, the company has surpassed consensus EPS estimates two times.

Southwest Gas, which belongs to the Zacks Utility - Gas Distribution industry, posted revenues of $585.12 million for the quarter ended March 2026, missing the Zacks Consensus Estimate by 20.61%. This compares to year-ago revenues of $1.3 billion. The company has not been able to beat consensus revenue estimates over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Southwest Gas shares have added about 16.3% since the beginning of the year versus the S&P 500's gain of 5.2%.

What's Next for Southwest Gas?While Southwest Gas has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Southwest Gas was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.55 on $608.33 million in revenues for the coming quarter and $4.27 on $2.01 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Utility - Gas Distribution is currently in the top 38% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

One other stock from the same industry, MDU Resources (MDU - Free Report) , is yet to report results for the quarter ended March 2026. The results are expected to be released on May 7.

This energy, mining, construction and utilities company is expected to post quarterly earnings of $0.42 per share in its upcoming report, which represents a year-over-year change of +5%. The consensus EPS estimate for the quarter has been revised 5.6% higher over the last 30 days to the current level.

MDU Resources' revenues are expected to be $702.32 million, up 4.1% from the year-ago quarter.

Southwest Gas Holdings, Inc. (SWX) Q1 2026 Earnings Call Transcript

Donates $60,000 to support the unhoused; Southwest Gas employees to prepare 6,000 personal care packages throughout the month to support individuals experiencing homelessness

, /PRNewswire/ -- The Southwest Gas Foundation ("Foundation"), the philanthropic arm of Southwest Gas Corporation ("Southwest Gas" or "Company"), is launching its "Month of Giving" this June in recognition of the Foundation's 60th anniversary, reflecting its long-standing commitment to uplifting and strengthening communities.

Southwest Gas logo During the Month of Giving, the Foundation will contribute $60,000 to provide essential hygiene items for a total of 6,000 care packages that will be distributed to unhoused individuals across Southwest Gas' service territories in Arizona, Nevada, and California through collaboration with local nonprofits. The care packages will be assembled by Southwest Gas employees through the employee volunteer program, BLUE ("Building Lives Up Everywhere"), which encourages employees to be of service to their neighbors and give back to the communities where they live and work. The care packages will be distributed by local nonprofit partners, including: Central Arizona Shelter Services, Northern Nevada Dream Center, Youth on Their Own, HELP of Southern Nevada, and Family Assistance Program.

"Southwest Gas plays a critical role in strengthening our communities, and giving back is core to our culture and mission," said Justin Brown, President and CEO of Southwest Gas. "For 60 years, the Southwest Gas Foundation has cultivated meaningful partnerships with local nonprofits to support our neighbors in need and truly make a difference in our communities. Our Month of Giving highlights these important partnerships and the collective work we do to uplift and enrich the lives of those we serve."

Below are scheduled BLUE events across the Company's service territory for the Month of Giving along with the total number of personal care packages that will be prepared:

June 6 Central Arizona: 2,000 care packages with Central Arizona Shelter Services June 13 Northern Nevada: 500 care packages with Northern Nevada Dream Center June 20 Southern Arizona: 1,000 care packages with Youth on Their Own Southern Nevada: 2,000 care packages with HELP of Southern Nevada Southern California: 500 care packages with Family Assistance Program A legacy of impact
Rooted in a deep commitment to people and the communities the Company serves, the Foundation has spent six decades partnering with 501(c)(3) organizations to open doors of opportunities, provide support in times of need; creating a legacy of impact that benefits generations to come. In 2025, through the Foundation, the Company donated $2.5 million to nonprofit organizations that share its vision of making a positive impact and supporting strong, sustainable communities.

For more information on the Foundation and its commitment to community, visit www.swgas.com/community.

About Southwest Gas
Southwest Gas Corporation is a dynamic energy company committed to exceeding the expectations of our over two million customers throughout Arizona, California, and Nevada by providing safe, reliable, and affordable service while innovating sustainable energy solutions to fuel our communities' growth. For more information about how Southwest Gas is supporting a sustainable energy future, please visit www.swgas.com. 

About The Southwest Gas Foundation
The Southwest Gas Foundation has spent six decades partnering with 501(c)(3) organizations to open doors of opportunities, provide support in times of need, and create a legacy of impact that benefits generations to come. Funded by shareholders, the Foundation is committed to enriching lives and strengthening communities. For more information, please visit www.swgas.com/community. 

SOURCE Southwest Gas Corporation

SWX gains from rising natural gas demand, customer growth and regulated operations, while infrastructure investments support long-term growth.

, /PRNewswire/ -- AMH (NYSE: AMH), a leading large-scale integrated owner, operator and developer of single-family rental homes, today announced that the Company will release its first quarter 2026 financial and operating results on Wednesday, May 6, 2026, after the market closes. The Company will host a conference call on Thursday, May 7, 2026, at 12:00 p.m. Eastern Time to review first quarter results, discuss recent events, and conduct a question-and-answer period.

Live conference call

Toll free number:

(877) 451-6152 (for domestic callers)

Direct dial number:

(201) 389-0879 (for international callers)

Passcode:

Not required

Simultaneous audio webcast link:

www.amh.com under "Investor relations"

Conference call replay

Toll free number:

(844) 512-2921 (for domestic callers)

Direct dial number:

(412) 317-6671 (for international callers)

Passcode:

13759161#

Webcast link:

www.amh.com under "Investor relations"

Date accessible through:

May 21, 2026

About AMH

AMH (NYSE: AMH) is a leading large-scale integrated owner, operator and developer of single-family rental homes. We're an internally managed Maryland real estate investment trust (REIT) focused on developing, renovating, leasing and managing homes as rental properties.

In recent years, we've been named a 2025 Great Place to Work®, a 2025 Top U.S. Homebuilder by Builder100, and one of the 2025 Most Trustworthy Companies in America by Newsweek and Statista Inc. As of December 31, 2025, we owned over 61,000 single-family properties in the Southeast, Midwest, Southwest and Mountain West regions of the United States. Additional information about AMH is available on our website at www.amh.com.

AMH refers to one or more of American Homes 4 Rent, American Homes 4 Rent, L.P. and their subsidiaries and joint ventures. In certain states, we operate under AMH Living or American Homes 4 Rent. Please see www.amh.com/dba to learn more.

AMH Contacts:

Brian Nelson
Media Relations
Phone: (855) 774-4663
Email: [email protected]

Nicholas Fromm
Investor Relations
Phone: (855) 794-2447
Email: [email protected]

SOURCE AMH